000			01563 a2200433 4500
005			20250517022359.0
264		0	_c20160620
008			201606s 0 0 eng d
022			_a1720-8386
024	7		_a10.1007/s40618-015-0263-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aChou, C-H
245	0	0	_a5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia. _h[electronic resource]
260			_bJournal of endocrinological investigation _cJul 2015
300			_a799-805 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a5-alpha Reductase Inhibitors _xadministration & dosage
650	0	4	_aAcute Coronary Syndrome _xchemically induced
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCase-Control Studies
650	0	4	_aDrug Therapy, Combination
650	0	4	_aDutasteride _xadministration & dosage
650	0	4	_aFinasteride _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNational Health Programs _xstatistics & numerical data
650	0	4	_aOdds Ratio
650	0	4	_aProstatic Hyperplasia _xdrug therapy
650	0	4	_aRisk
650	0	4	_aTaiwan _xepidemiology
700	1		_aLin, C-L
700	1		_aLin, M-C
700	1		_aSung, F-C
700	1		_aKao, C-H
773	0		_tJournal of endocrinological investigation _gvol. 38 _gno. 7 _gp. 799-805
856	4	0	_uhttps://doi.org/10.1007/s40618-015-0263-1 _zAvailable from publisher's website
999			_c24714220 _d24714220